尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Simon Barry J., Director. Insider active across 1 company, notably ImmunityBio, Inc.. In total, 10 disclosures have been published. Breakdown: 0 buy · 5 sells. Total volume traded: €1.5m. Activity tracked since 5 May 2021. The latest transaction was disclosed on 24 February 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Barry J. Simon is a Director at ImmunityBio, Inc. In this role, he participates in the governance of the company, contributing to strategic decision-making and oversight of operations. His expertise in the biopharmaceutical sector is valuable in guiding management and ensuring compliance with regulations. As a director, he plays a key role in developing the company's policies.